Media Pack
News

Current Edition

JCS Volume 15 Issue 3
 
Volume 14 Issue 2

Achieving Diversity and Inclusion in COVID-19 Vaccination Trials

Moderna’s COVID-19 mRNA vaccine trial was one of the most diverse clinical trials in history. LaQuinta Jernigan, Executive Vice President for the Americas at mdgroup ...
1 April 2022 Volume 14 Issue 2
Continue Reading →
Volume 14 Issue 2

A Long but Worthwhile Wait for Vitiligo Treatments

The drug development landscape for vitiligo is sparse despite its social impact on individuals irrespective of race, ethnicity, or gender. Sometimes dubbed a “cosmeti...
1 April 2022 Volume 14 Issue 2
Continue Reading →
Volume 14 Issue 2

Accelerating the Transformation of Healthcare through Open-Source Algorithms

Wearables have the potential to transform healthcare. They can help to inform timely, data-driven interventions. But validating each new digital measure is time-consu...
1 April 2022 Volume 14 Issue 2
Continue Reading →
Volume 14 Issue 2

Six Ways the Shift to Digital Will Redefine Product Development in 2022

This past year has seen life sciences companies settle into new operating models and digital ways of working, many of whom have come to realise that a return to the p...
1 April 2022 Volume 14 Issue 2
Continue Reading →
Volume 14 Issue 2

Overcoming the Challenges of Obtaining Informed Consent During the Pandemic

The COVID-19 pandemic created a public health emergency that has had a profound impact on all aspects of the clinical trial industry. Quarantine requirements and limi...
1 April 2022 Volume 14 Issue 2
Continue Reading →
Volume 14 Issue 2

Why Risk-Based Quality Management Represents the Future of Clinical Research

By empowering researchers to detect data quality issues in real-time, Risk-Based Quality Management (RBQM) and Risk-Based Monitoring (RBM) have proven their value dur...
1 April 2022 Volume 14 Issue 2
Continue Reading →
Volume 14 Issue 2

Growing the Pool of Clinical Research Investigators in Malaysia

The Malaysian government has continuously strived to improve and expand its clinical research ecosystem for the past ten years. The primary goal is to provide a compe...
1 April 2022 Volume 14 Issue 2
Continue Reading →
Volume 14 Issue 2

Personalised Medicine and Clinical Studies – The Attempt to Untie a Gordian Knot –

Classical drug development is undoubtedly indication- and product-driven. Simply put, a preclinically developed substance is optimised for clinical application in an ...
1 April 2022 Volume 14 Issue 2
Continue Reading →
Volume 14 Issue 2

Blinding and Therapeutic Setting Key to Success

Pharma Starts its Psychedelic Journey Steffanie Wilson at The Emmes Company affirms that both public and medical opinion is changing quickly and substances that were...
1 April 2022 Volume 14 Issue 2
Continue Reading →
Volume 14 Issue 2

Artificial Intelligence in Clinical & Medical Research

While clinical trials have become lengthy and very costly with low success rates, the application of innovative artificial intelligence (AI)- based approaches has bee...
1 April 2022 Volume 14 Issue 2
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2023, All Rights Reserved – Powered by Teksyte